Company / Current Assets
Tango Therapeutics, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$353.8M
FY2025
5-year range
$266.3M / $492.3M
FY2021-FY2025
Trend
+32.8%
vs FY2024
Sector context
#145 of 213
Health Care
What the data says
At $354M, Tango Therapeutics, Inc.'s current assets ranks #145 of 213 in the Health Care sector. Current Assets returned to growth in FY2025 after 3 years of decline, reaching $354M.
Based on SEC 10-K filings.
$354M in FY2025 with a 5-year CAGR of +12.8%.
Improved from $347M to $354M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
#145 of 213 in Health CareTop 68% of 213This company $353.8M Sector average $2.5B
▼
-86.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.8%, indicating consistent growth.
- In FY2025, current assets increased 32.8% year-over-year.
- Ranks #145 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $353.8M | +32.8% |
| FY2024 | $266.3M | -23.1% |
| FY2023 | $346.5M | -7.7% |
| FY2022 | $375.3M | -23.8% |
| FY2021 | $492.3M | +154.3% |
| FY2020 | $193.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026